Clustering based on adherence data.

Adherence to a medical treatment means the extent to which a patient follows the instructions or recommendations by health professionals. There are direct and indirect ways to measure adherence which have been used for clinical management and research. Typically adherence measures are monitored over...

Full description

Bibliographic Details
Main Authors: Kiwuwa-Muyingo, S, Oja, H, Walker, SA, Ilmonen, P, Levin, J, Todd, J
Format: Journal article
Language:English
Published: 2011
_version_ 1797086466292056064
author Kiwuwa-Muyingo, S
Oja, H
Walker, SA
Ilmonen, P
Levin, J
Todd, J
author_facet Kiwuwa-Muyingo, S
Oja, H
Walker, SA
Ilmonen, P
Levin, J
Todd, J
author_sort Kiwuwa-Muyingo, S
collection OXFORD
description Adherence to a medical treatment means the extent to which a patient follows the instructions or recommendations by health professionals. There are direct and indirect ways to measure adherence which have been used for clinical management and research. Typically adherence measures are monitored over a long follow-up or treatment period, and some measurements may be missing due to death or other reasons. A natural question then is how to describe adherence behavior over the whole period in a simple way. In the literature, measurements over a period are usually combined just by using averages like percentages of compliant days or percentages of doses taken. In the paper we adapt an approach where patient adherence measures are seen as a stochastic process. Repeated measures are then analyzed as a Markov chain with finite number of states rather than as independent and identically distributed observations, and the transition probabilities between the states are assumed to fully describe the behavior of a patient. The patients can then be clustered or classified using their estimated transition probabilities. These natural clusters can be used to describe the adherence of the patients, to find predictors for adherence, and to predict the future events. The new approach is illustrated and shown to be useful with a simple analysis of a data set from the DART (Development of AntiRetroviral Therapy in Africa) trial in Uganda and Zimbabwe.
first_indexed 2024-03-07T02:22:26Z
format Journal article
id oxford-uuid:a46696ae-9dc7-44a4-a566-f32c89226dc0
institution University of Oxford
language English
last_indexed 2024-03-07T02:22:26Z
publishDate 2011
record_format dspace
spelling oxford-uuid:a46696ae-9dc7-44a4-a566-f32c89226dc02022-03-27T02:33:40ZClustering based on adherence data.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a46696ae-9dc7-44a4-a566-f32c89226dc0EnglishSymplectic Elements at Oxford2011Kiwuwa-Muyingo, SOja, HWalker, SAIlmonen, PLevin, JTodd, JAdherence to a medical treatment means the extent to which a patient follows the instructions or recommendations by health professionals. There are direct and indirect ways to measure adherence which have been used for clinical management and research. Typically adherence measures are monitored over a long follow-up or treatment period, and some measurements may be missing due to death or other reasons. A natural question then is how to describe adherence behavior over the whole period in a simple way. In the literature, measurements over a period are usually combined just by using averages like percentages of compliant days or percentages of doses taken. In the paper we adapt an approach where patient adherence measures are seen as a stochastic process. Repeated measures are then analyzed as a Markov chain with finite number of states rather than as independent and identically distributed observations, and the transition probabilities between the states are assumed to fully describe the behavior of a patient. The patients can then be clustered or classified using their estimated transition probabilities. These natural clusters can be used to describe the adherence of the patients, to find predictors for adherence, and to predict the future events. The new approach is illustrated and shown to be useful with a simple analysis of a data set from the DART (Development of AntiRetroviral Therapy in Africa) trial in Uganda and Zimbabwe.
spellingShingle Kiwuwa-Muyingo, S
Oja, H
Walker, SA
Ilmonen, P
Levin, J
Todd, J
Clustering based on adherence data.
title Clustering based on adherence data.
title_full Clustering based on adherence data.
title_fullStr Clustering based on adherence data.
title_full_unstemmed Clustering based on adherence data.
title_short Clustering based on adherence data.
title_sort clustering based on adherence data
work_keys_str_mv AT kiwuwamuyingos clusteringbasedonadherencedata
AT ojah clusteringbasedonadherencedata
AT walkersa clusteringbasedonadherencedata
AT ilmonenp clusteringbasedonadherencedata
AT levinj clusteringbasedonadherencedata
AT toddj clusteringbasedonadherencedata